Intranasal DHE Safe for Acute Migraine: STOP 301 Published ...Middle East

An intranasal formulation of dihydroergotamine is safe and well-tolerated for the treatment of acute migraine, according to newly published findings from the open-label phase 3 STOP-301 trial. Medscape Medical News

Hence then, the article about intranasal dhe safe for acute migraine stop 301 published was published today ( Wednesday 18/08/2021 - 08:45 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Intranasal DHE Safe for Acute Migraine: STOP 301 Published )

Also on site :

• Peter Alexander is leaving NBC after years of being passed over for top anchor jobs: source
• This Can't Miss Scenic Spot Just Under an Hour from Vegas Will Have You Feeling Like You're in Another World
• This Spring, Divest From Clutter to Reclaim Personal Productivity Like a Boss .. PYMNTS.com